Cargando…
Anti-VEGF agents: As appealing targets in the setting of COVID-19 treatment in critically ill patients
Recently, the medications used for the severe form of the coronavirus disease-19 (COVID-19) therapy are of particular interest. In this sense, it has been supposed that anti-VEGF compounds would be good candidates in the face of “cytokine storm” and intussuscepted angiogenesis due to having an appre...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier B.V.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8519896/ https://www.ncbi.nlm.nih.gov/pubmed/34673299 http://dx.doi.org/10.1016/j.intimp.2021.108257 |